These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1321 related items for PubMed ID: 9098260

  • 1. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
    Power WJ, Ghoraishi M, Merayo-Lloves J, Neves RA, Foster CS.
    Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
    [Abstract] [Full Text] [Related]

  • 2. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC, SCAR Study Group. Severe Cutaneous Adverse Reactions.
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [Abstract] [Full Text] [Related]

  • 3. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM.
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [Abstract] [Full Text] [Related]

  • 4. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Wilkins J, Morrison L, White CR.
    Dermatol Clin; 1992 Jul; 10(3):571-82. PubMed ID: 1617814
    [Abstract] [Full Text] [Related]

  • 5. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
    Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC.
    Arch Dermatol; 1993 Jan; 129(1):92-6. PubMed ID: 8420497
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year retrospective study.
    Chow LLW, Shih KC, Chan JCY, Lai JSM, Ng ALK.
    BMC Ophthalmol; 2017 May 12; 17(1):65. PubMed ID: 28499410
    [Abstract] [Full Text] [Related]

  • 7. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme.
    Roujeau JC.
    J Dermatol; 1997 Nov 12; 24(11):726-9. PubMed ID: 9433029
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Erythema multiforme, Stevens-Johnson Syndrome, and toxic epidermal necrolysis.
    Rasmussen JE.
    Dermatol Nurs; 1995 Feb 12; 7(1):37-43. PubMed ID: 7756086
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME, Purdue GF, Verity SM, Arnoldo BD, Blomquist PH.
    Am J Ophthalmol; 2010 Oct 12; 150(4):505-510.e1. PubMed ID: 20619392
    [Abstract] [Full Text] [Related]

  • 13. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Ukponmwan CU, Njinaka I, Ehimiyen ET.
    Trop Doct; 2010 Jul 12; 40(3):167-8. PubMed ID: 20555046
    [Abstract] [Full Text] [Related]

  • 14. Ocular manifestations in acute stage Stevens-Johnson syndrome/toxic epidermal necrolysis - A retrospective study in a tertiary hospital in South India.
    Pradeep TG, Shetti SA.
    Taiwan J Ophthalmol; 2022 Jul 12; 12(2):184-190. PubMed ID: 35813799
    [Abstract] [Full Text] [Related]

  • 15. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Gueudry J, Roujeau JC, Binaghi M, Soubrane G, Muraine M.
    Arch Dermatol; 2009 Feb 12; 145(2):157-62. PubMed ID: 19221260
    [Abstract] [Full Text] [Related]

  • 16. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
    Saka B, Dzidzinyo K, Akakpo S, Téclessou J, Nouhou Diori A, Maneh N, Mahamadou G, Gnassingbé W, Abilogun-Chokki A, Mouhari-Toure A, Boubacar YA, Kombaté K, Balo K, Tchangai-Walla K, Pitché P.
    Ann Dermatol Venereol; 2018 Apr 12; 145(4):245-249. PubMed ID: 29487020
    [Abstract] [Full Text] [Related]

  • 17. Morbidity and mortality of mucocutaneous diseases in the pediatric population at a tertiary care center.
    Dore J, Salisbury RE.
    J Burn Care Res; 2007 Apr 12; 28(6):865-70. PubMed ID: 17925657
    [Abstract] [Full Text] [Related]

  • 18. Relationship between Atopic Disease and Acute Ocular and Systemic Outcomes in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    Kwan J, Ahmed H, Ponsetto MK, Succar T, Chodosh J, Saeed HN.
    Ocul Immunol Inflamm; 2023 Jul 12; 31(5):900-904. PubMed ID: 35486647
    [Abstract] [Full Text] [Related]

  • 19. Erythema multiforme: a review and contrast from Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Williams PM, Conklin RJ.
    Dent Clin North Am; 2005 Jan 12; 49(1):67-76, viii. PubMed ID: 15567361
    [Abstract] [Full Text] [Related]

  • 20. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
    Ueta M.
    Expert Rev Clin Immunol; 2020 Mar 12; 16(3):285-291. PubMed ID: 32045311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.